Intrinsiqs

Is The Joint Corp. overvalued?

The Joint Corp. (JYNT) looks overvalued — trading about 47% above its fair value.

Overvalued
Current price $8.45 Fair value $4.50
Price
$8.45
Fair value
$4.50
Current P/E
84.5
Normal P/E
45.0
Market cap
$120.5M
Dividend yield
0.0%
Return on equity
22.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares JYNT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.